Indeloxazine

Source: Wikipedia, the free encyclopedia.
Indeloxazine
Clinical data
Other namesCI-874, YM-08054
ATC code
  • None
Legal status
Legal status
  • Discontinued
Identifiers
  • 2-(3H-Inden-4-yloxymethyl)morpholine
JSmol)
  • O(c1cccc2\C=C/Cc12)CC3OCCNC3
  • InChI=1S/C14H17NO2/c1-3-11-4-2-6-14(13(11)5-1)17-10-12-9-15-7-8-16-12/h1-4,6,12,15H,5,7-10H2 checkY
  • Key:MADRVGBADLFHMO-UHFFFAOYSA-N checkY
  (verify)

Indeloxazine (

Yamanouchi Pharmaceutical Co., Ltd for the treatment of psychiatric symptoms associated with cerebrovascular diseases, namely depression resulting from stroke, emotional disturbance, and avolition.[3][4] It was marketed from 1988[4] to 1998, when it was removed from the market reportedly for lack of effectiveness.[5]

Indeloxazine acts as a

animal models.[1][6]

References

  1. ^
    PMID 4092278
    .
  2. PMID 6841538
    .
  3. ISBN 978-3-88763-075-1
    .
  4. ^
    ISBN 978-0-412-46630-4
    .
  5. S2CID 43687432
    .
  6. ^
    S2CID 12707551
    .
  7. PMID 1652446
    .
  8. S2CID 14116338
    .
  9. S2CID 7800009. Archived from the original
    on 1999-10-08. Retrieved 2010-01-11.
  10. S2CID 11703415
    .
  11. PMID 3219685
    .
  12. S2CID 46153252
    .
  13. PMID 3187197
    .
  14. PMID 3446040
    .
  15. PMID 8297184
    .
  16. PMID 3592867
    .
  17. S2CID 26761718
    .